1. Home
  2. HUBC vs LGVN Comparison

HUBC vs LGVN Comparison

Compare HUBC & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUBC
  • LGVN
  • Stock Information
  • Founded
  • HUBC 2017
  • LGVN 2014
  • Country
  • HUBC Israel
  • LGVN United States
  • Employees
  • HUBC N/A
  • LGVN N/A
  • Industry
  • HUBC
  • LGVN Medicinal Chemicals and Botanical Products
  • Sector
  • HUBC
  • LGVN Health Care
  • Exchange
  • HUBC Nasdaq
  • LGVN Nasdaq
  • Market Cap
  • HUBC 21.7M
  • LGVN 23.4M
  • IPO Year
  • HUBC N/A
  • LGVN 2021
  • Fundamental
  • Price
  • HUBC $2.21
  • LGVN $1.23
  • Analyst Decision
  • HUBC
  • LGVN Strong Buy
  • Analyst Count
  • HUBC 0
  • LGVN 3
  • Target Price
  • HUBC N/A
  • LGVN $8.67
  • AVG Volume (30 Days)
  • HUBC 255.5K
  • LGVN 132.9K
  • Earning Date
  • HUBC 05-01-2025
  • LGVN 05-08-2025
  • Dividend Yield
  • HUBC N/A
  • LGVN N/A
  • EPS Growth
  • HUBC N/A
  • LGVN N/A
  • EPS
  • HUBC N/A
  • LGVN N/A
  • Revenue
  • HUBC $29,562,000.00
  • LGVN $2,225,000.00
  • Revenue This Year
  • HUBC N/A
  • LGVN N/A
  • Revenue Next Year
  • HUBC N/A
  • LGVN $24.82
  • P/E Ratio
  • HUBC N/A
  • LGVN N/A
  • Revenue Growth
  • HUBC N/A
  • LGVN 127.50
  • 52 Week Low
  • HUBC $2.06
  • LGVN $0.77
  • 52 Week High
  • HUBC $14.00
  • LGVN $6.40
  • Technical
  • Relative Strength Index (RSI)
  • HUBC 36.80
  • LGVN 39.93
  • Support Level
  • HUBC $2.06
  • LGVN $1.25
  • Resistance Level
  • HUBC $2.55
  • LGVN $1.37
  • Average True Range (ATR)
  • HUBC 0.17
  • LGVN 0.09
  • MACD
  • HUBC 0.02
  • LGVN -0.01
  • Stochastic Oscillator
  • HUBC 26.69
  • LGVN 30.00

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Share on Social Networks: